{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:46:03Z","timestamp":1767869163617,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.ajog.2006.12.025","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T07:12:44Z","timestamp":1175497964000},"page":"402.e1-402.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome"],"prefix":"10.1016","volume":"196","author":[{"given":"Richard S.","family":"Legro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Zaino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence M.","family":"Demers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen R.","family":"Kunselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Gnatuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy I.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2006.12.025_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ajog.2006.12.025_bib3","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2006.12.025_bib4","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib5","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib7","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2006.12.025_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2006.12.025_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ajog.2006.12.025_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2006.12.025_bib13","first-page":"325","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.12.025_bib14","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2006.12.025_bib15","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2006.12.025_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.12.025_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI0,120): comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2006.12.025_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2006.12.025_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0301-5629(91)90029-V","article-title":"Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances","volume":"17","author":"Pache","year":"1991","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.ajog.2006.12.025_bib20","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2006.12.025_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/49.7.1139","article-title":"Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research","volume":"49","author":"O\u2019Connor","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2006.12.025_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0015-0282(16)56815-0","article-title":"Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use","volume":"62","author":"Jordan","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00005768-199607000-00002","article-title":"Bone density and cyclic ovarian function in trained runners and active controls","volume":"28","author":"Winters","year":"1996","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ajog.2006.12.025_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/clinchem\/37.6.838","article-title":"Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay","volume":"37","author":"Munro","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2006.12.025_bib26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1097\/00005768-200211000-00022","article-title":"Validity of methods for analyzing urinary steroid data to detect ovulation in athletes","volume":"34","author":"McConnell","year":"2002","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ajog.2006.12.025_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.fertnstert.2003.11.030","article-title":"A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women","volume":"81","author":"Murray","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1289\/ehp.96104408","article-title":"Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm","volume":"104","author":"Kassam","year":"1996","journal-title":"Environment Health Perspect"},{"key":"10.1016\/j.ajog.2006.12.025_bib30","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archinte.161.13.1581","article-title":"Impact of overweight on the risk of developing common chronic diseases during a 10-year period","volume":"161","author":"Field","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2006.12.025_bib31","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ajog.2006.12.025_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590500231627","article-title":"The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome","volume":"21","author":"Yilmaz","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2006.12.025_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2005.11.019","article-title":"Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome","volume":"126","author":"Mitkov","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2006.12.025_bib35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/deh322","article-title":"Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?","volume":"19","author":"Legro","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2006.12.025_bib36","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2265.2005.02269.x","article-title":"Glycodelin responses to hyperinsulinaemic clamp vary according to basal serum glycodelin concentration","volume":"62","author":"Seppala","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2006.12.025_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/humrep\/dei351","article-title":"Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2006.12.025_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2006.12.025_bib40","first-page":"1841","article-title":"PPAR-\u03b3 decreases endometrial stromal cell transcription and translation of RANTES in vitro","volume":"87","author":"Pritts","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"10.1016\/j.ajog.2006.12.025_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2004.02.148","article-title":"Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis","volume":"82","author":"Lebovic","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2006.12.025_bib43","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib44","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib45","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2006.12.025_bib46","first-page":"954","article-title":"Pipelle endometrial sampling in patients with known endometrial carcinoma","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2006.12.025_bib47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-0528.1992.tb13887.x","article-title":"Histological sampling of the endometrium: a comparison between formal curettage and the Pipelle sampler","volume":"99","author":"Fothergill","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2006.12.025_bib48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.fertnstert.2004.03.069","article-title":"Histological dating of timed endometrial biopsy tissue is not related to fertility status","volume":"82","author":"Coutifaris","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2006.12.025_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/00912709922007985","article-title":"Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent","volume":"39","author":"Loi","year":"1999","journal-title":"J Clin Pharmacol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806024677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937806024677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:22:15Z","timestamp":1757586135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937806024677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0002937806024677"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2006.12.025","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2006.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}